These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14726400)

  • 1. Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas.
    Grange F; Petrella T; Beylot-Barry M; Joly P; D'Incan M; Delaunay M; Machet L; Avril MF; Dalac S; Bernard P; Carlotti A; Esteve E; Vergier B; Dechelotte P; Cassagnau E; Courville P; Saiag P; Laroche L; Bagot M; Wechsler J
    Blood; 2004 May; 103(10):3662-8. PubMed ID: 14726400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
    Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study.
    Grange F; Bekkenk MW; Wechsler J; Meijer CJ; Cerroni L; Bernengo M; Bosq J; Hedelin G; Fink Puches R; van Vloten WA; Joly P; Bagot M; Willemze R
    J Clin Oncol; 2001 Aug; 19(16):3602-10. PubMed ID: 11504742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognosis of primary cutaneous lymphomas].
    Grange F; Bagot M
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):30-40. PubMed ID: 11937927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
    Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
    J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance.
    Hoefnagel JJ; Vermeer MH; Jansen PM; Fleuren GJ; Meijer CJ; Willemze R
    Br J Dermatol; 2003 Dec; 149(6):1183-91. PubMed ID: 14674895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous large B-cell lymphoma: the relation between morphology, clinical presentation, immunohistochemical markers, and survival.
    Fernández-Vázquez A; Rodríguez-Peralto JL; Martínez MA; Platón EM; Algara P; Camacho FI; López-Ríos F; Zarco C; Sánchez-Yus E; Fresno MF; Barthe L; Aliaga A; Fraga M; Forteza J; Oliva H; Piris MA
    Am J Surg Pathol; 2001 Mar; 25(3):307-15. PubMed ID: 11224600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous diffuse large B-cell lymphoma: prognostic significance of clinicopathological subtypes.
    Goodlad JR; Krajewski AS; Batstone PJ; McKay P; White JM; Benton EC; Kavanagh GM; Lucraft HH;
    Am J Surg Pathol; 2003 Dec; 27(12):1538-45. PubMed ID: 14657713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome. The French Study Group on Cutaneous Lymphomas.
    Grange F; Hedelin G; Joly P; Beylot-Barry M; D'Incan M; Delaunay M; Vaillant L; Avril MF; Bosq J; Wechsler J; Dalac S; Grosieux C; Franck N; Esteve E; Michel C; Bodemer C; Vergier B; Laroche L; Bagot M
    Blood; 1999 Jun; 93(11):3637-42. PubMed ID: 10339469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Fas and Fas ligand in cutaneous B-cell lymphomas.
    Zoi-Toli O; Meijer CJ; Oudejans JJ; de Vries E; van Beek P; Willemze R
    J Pathol; 1999 Dec; 189(4):533-8. PubMed ID: 10629554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cutaneous B-cell lymphoma in Japanese patients.
    Liu Q; Ohshima K; Kikuchi M
    Pathol Int; 2000 Dec; 50(12):960-6. PubMed ID: 11123762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in France.
    Grange F; Joly P; Barbe C; Bagot M; Dalle S; Ingen-Housz-Oro S; Maubec E; D'Incan M; Ram-Wolff C; Dalac S; Templier I; Esteve E; Quereux G; Machet L; Leduc M; Dereure O; Laroche L; Saiag P; Vergier B; Beylot-Barry M
    JAMA Dermatol; 2014 May; 150(5):535-41. PubMed ID: 24647650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases.
    Menguy S; Beylot-Barry M; Parrens M; Ledard AP; Frison E; Comoz F; Battistella M; Szablewski V; Balme B; Croue A; Franck F; Ortonne N; Tournier E; Lamant L; Carlotti A; De Muret A; Le Gall F; Lorton MH; Merlio JP; Vergier B
    Histopathology; 2019 Jun; 74(7):1067-1080. PubMed ID: 30715765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous medium and large cell lymphomas other than mycosis fungoides. An immunohistological and follow-up study on 54 cases. French Study Group for Cutaneous Lymphomas.
    Joly P; Vasseur E; Esteve E; Leibowitch M; Tilly H; Vaillant L; Wechsler J; Thomine E; De Muret A; Dreyfus F
    Br J Dermatol; 1995 Apr; 132(4):506-12. PubMed ID: 7748738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related.
    Geelen FA; Vermeer MH; Meijer CJ; Van der Putte SC; Kerkhof E; Kluin PM; Willemze R
    J Clin Oncol; 1998 Jun; 16(6):2080-5. PubMed ID: 9626207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cutaneous B-cell lymphomas of the lower limbs: a study of integrin expression in 11 cases.
    Lair G; Parant E; Tessier MH; Jumbou O; Dreno B
    Acta Derm Venereol; 2000; 80(5):367-9. PubMed ID: 11200836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
    de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
    Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study.
    Sundram U; Kim Y; Mraz-Gernhard S; Hoppe R; Natkunam Y; Kohler S
    J Cutan Pathol; 2005 Mar; 32(3):227-34. PubMed ID: 15701085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of bcl-6, CD10 and CD38 immunoreactivity in stage I-II gastric lymphomas: identification of a subset of CD10+ large B-cell lymphomas with a favorable outcome.
    Ponzoni M; Ferreri AJ; Pruneri G; Pozzi B; Dell'Oro S; Pigni A; Pinotti G; Villa E; Freschi M; Viale G; Capella C
    Int J Cancer; 2003 Aug; 106(2):288-91. PubMed ID: 12800208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group.
    Vermeer MH; Geelen FA; van Haselen CW; van Voorst Vader PC; Geerts ML; van Vloten WA; Willemze R
    Arch Dermatol; 1996 Nov; 132(11):1304-8. PubMed ID: 8915307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.